News
Wellness provider Reviv Global is claiming a “world first” in the field of personalised health with the UK launch of its 10X Precision Health System. Launched in partnership with private equity jamp fer ferrous fumarate 300mgpartner Cardonemagnesium glycinate and melatonin together Investments, the system is backed by Reviv’s 10X Precision Genetic Test, which uses artificial intelligence (AI) to analyse up to 20 million genetic variations, delivering accurate insights into an individual’s biological data. Reviv, which specialises in personalised health and IV therapy, says the system provides a unique way for individuals to optimise their health and wellness. The company is launching the system in the UK first as part of a strategic international rollout. Tony Lever, chief revenue officer at Reviv/10X, explained why the UK was chosen as the market for the rollout, saying: “The UK is currently experiencing a significant shift towards personalised health and wellness solutions. “Consumers are increasingly moving away from one-size-fits-all approaches to nutrition and looking for tailored strategies that align with their unique genetic makeup.”Addressing the targeted global rollout, Lever pointed to four key areas that are expected to drive demand for the 10X Precision Health System: greater consumer awareness of genetic health; the rise of precision medicine and preventative health; demand for science-backed personalisation; and a shift toward longevity and performance optimisation.“The 10X Precision Nutrition System addresses all these demands by offering a data-driven, genetically tailored approach to health, making this the perfect time for its UK launch,” he said.The system, which was developed in Austria by biotechnologist Dr Daniel Wallerstorfer, uses an oral swab to collect DNA that is then analysed at a lab that can detect 700,000 DNA variations. The company says that AI-powered bioinformatics expand the analysis to 20 million variations, delivering a detailed, actionable report within just six weeks. This report is more than 400 pages long, pointing to health and lifestyle facgeneric name for ferrous gluconatetors such as caffeine intake, inflammation, and fat distribution. The results give Reviv customers access to personalised therapies that include a range of customised supplements, together with an IV drip that is specifically designed to meet wellness benefits that are tailored around the individual’s genetic profile. The IV therapies are administered from a network of 10X clinics located worldwide.“The 10X Precision Nutrition System is the first and only fully integrated precision health platform that combines advanced genetic testing, personalised supplementation, and precision IV therapy into one seamless program,” said Lever. “While genezinc bisglycinate vs zinc bisglycinate chelatetic testing and personalised supplements exist separately, this system is the first to bring all three elements together in a fully customised, scientifically validated approach to health optimisation.”While the UK is the first nation where Reviv has launched the system, the company is eyeing a global rollout, targeting significant projected growth. According to Vantage Market Research, the global market for personalised healthcare was estimated to be worth $565.5 billion in 2024, and is projected to be worth more than $1,200 billion by 2034.“The UK launch marks a major milestone for the 10X Precision Nutrition System, but the vision is global. Following the success in the US and the UK, expansion into other key international markets iwhat does zinc glycinate do for yous already being planned,” said Lever.The global launch will included countries like Germany, France, and Spain in continental Europe, together with Australasia, Canada, and the Middle East, all of which have been singled out for significant growth in personalised and preventative health therapies. “As the global movement toward precision health accelerates, the 10X Precision Nutrition System is poised to redefine how people worldwide approach their wellbeing, performance, and longevity,” said Lever.